Maunsell Farris Maryanne has filed 8 insider transactions across 1 company since May 2024.
Most recent transaction: a grant/award of 2662 shares of HAEMONETICS CORP ($HAE) on June 05, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 5, 2025 | HAEMONETICS CORP | $HAE | Maunsell Farris Maryanne | VP, Chief Accounting Officer | A | Common Stock | 2662 | $0.00 | 4,478.0000 | 50,730,000 | 146.59% | 0.01% |
| May 16, 2025 | HAEMONETICS CORP | $HAE | Maunsell Farris Maryanne | VP, Chief Accounting Officer | A | Common Stock | 800 | $0.00 | 1,816.0000 | 50,730,000 | 78.74% | 0.00% |
| May 16, 2025 | HAEMONETICS CORP | $HAE | Maunsell Farris Maryanne | VP, Chief Accounting Officer | A | Non-qualified Stock Option (Right to Buy) | 1732 | $0.00 | 1,732.0000 | 50,730,000 | 9999.99% | 0.00% |
| May 15, 2025 | HAEMONETICS CORP | $HAE | Maunsell Farris Maryanne | VP, Chief Accounting Officer | F | Common Stock | 60 | $69.38 | 1,084.0000 | 50,730,000 | 5.24% | 0.00% |
| May 16, 2025 | HAEMONETICS CORP | $HAE | Maunsell Farris Maryanne | VP, Chief Accounting Officer | F | Common Stock | 68 | $70.31 | 1,016.0000 | 50,730,000 | 6.27% | 0.00% |
| May 17, 2024 | HAEMONETICS CORP | $HAE | Maunsell Farris Maryanne | VP, Chief Accounting Officer | A | Common Stock | 587 | $0.00 | 1,144.0000 | 51,397,000 | 105.39% | 0.00% |
| May 17, 2024 | HAEMONETICS CORP | $HAE | Maunsell Farris Maryanne | VP, Chief Accounting Officer | A | Non-qualified Stock Option (Right to Buy) | 1291 | $0.00 | 1,291.0000 | 51,397,000 | 9999.99% | 0.00% |
| May 15, 2024 | HAEMONETICS CORP | $HAE | Maunsell Farris Maryanne | VP, Chief Accounting Officer | F | Common Stock | 73 | $96.49 | 557.0000 | 51,397,000 | 11.59% | 0.00% |